Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition
Journal of Experimental Medicine · 2023
DOI: 10.1084/jem.20212383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2023. Verfasst von Hesham D Abdulla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Walter and Eliza Hall Institute of Medical Research , Parkville, Australia. Hauptthemen laut MEDLINE: Thymocytes, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Australian Government, National Health and Medical Research Council, Cancer Council of Victoria.
Abstract (Originalsprache)
Cell competition has recently emerged as an important tumor suppressor mechanism in the thymus that inhibits autonomous thymic maintenance. Here, we show that the oncogenic transcription factor Lmo2 causes autonomous thymic maintenance in transgenic mice by inhibiting early T cell differentiation. This autonomous thymic maintenance results in the development of self-renewing preleukemic stem cells (pre-LSCs) and subsequent leukemogenesis, both of which are profoundly inhibited by restoration of thymic competition or expression of the antiapoptotic factor BCL2. Genomic analyses revealed the presence of Notch1 mutations in pre-LSCs before subsequent loss of tumor suppressors promotes the transition to overt leukemogenesis. These studies demonstrate a critical role for impaired cell competition in the development of pre-LSCs in a transgenic mouse model of T cell acute lymphoblastic leukemia (T-ALL), implying that this process plays a role in the ontogeny of human T-ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Walter and Eliza Hall Institute of Medical Research , Parkville, Australia.
- Department of Medical Biology, University of Melbourne , Parkville, Australia.
- College of Applied Medical Sciences, King Abdul-Aziz University , Jeddah, Saudi Arabia.
- Westlake Laboratory of Life Sciences and Biomedicine , Hangzhou, China.
- School of Life Sciences, Westlake University , Hangzhou, China.
- Westlake Institute for Advanced Study , Hangzhou, China.
ORCID-Profile: Hesham D Abdulla, Raed Alserihi, Christoffer Flensburg, Waruni Abeysekera, Meng-Xiao Luo, Daniel H D Gray, Xiaodong Liu, Gordon K Smyth, Warren S Alexander, Ian J Majewski, Matthew P McCormack
Förderung
- Australian Government
- National Health and Medical Research Council
- Cancer Council of Victoria
- Australian Research Council
- Victorian State Government
Zitieren
APA
Abdulla, H. D., Alserihi, R., Flensburg, C., Abeysekera, W., Luo, M. X., Gray, D. H. D., Liu, X., Smyth, G. K., Alexander, W. S., Majewski, I. J., & McCormack, M. P. (2023). Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20212383
Vancouver
Abdulla HD, Alserihi R, Flensburg C, Abeysekera W, Luo MX, Gray DHD, et al. Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition. Journal of Experimental Medicine. 2023. doi:10.1084/jem.20212383
BibTeX
@article{Abdulla2023,
author = {Abdulla, Hesham D and Alserihi, Raed and Flensburg, Christoffer and Abeysekera, Waruni and Luo, Meng-Xiao and Gray, Daniel H D and Liu, Xiaodong and Smyth, Gordon K and Alexander, Warren S and Majewski, Ian J and McCormack, Matthew P},
title = {Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition},
journal = {Journal of Experimental Medicine},
year = {2023},
doi = {10.1084/jem.20212383}
}
EUVIMED